The EMA has issued advice to member states on potentially pre-approval use of Pfizer’s anti-COVID-19 treatment Paxlovid while a rolling review of data is ongoing
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.